Alyeska Investment Group L.P. Invests $174.36 Million in CVS Health Corporation $CVS

Key Points

• Alyeska Investment Group acquired 1.69 million CVS shares worth approximately $174.4 million in the second quarter, giving it about a 0.13% stake. Institutional investors and hedge funds collectively own 80.66% of CVS.
• CVS reported quarterly earnings of $2.58 per share, beating the $1.87 consensus estimate, while revenue rose 7.3% year over year to $106.1 billion. The company maintained fiscal 2026 EPS guidance of $7.90–$8.10.
• CVS pays a quarterly dividend of $0.665, equivalent to a 2.9% annual yield, and analysts maintain a “Moderate Buy” consensus with an average price target of $107.17 versus the reported $93.15 share price.

Alyeska Investment Group L.P. acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,685,440 shares of the pharmacy operator's stock, valued at approximately $174,359,000. Alyeska Investment Group L.P. owned approximately 0.13% of CVS Health at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Flputnam Investment Management Co. boosted its stake in CVS Health by 4.9% in the second quarter. Flputnam Investment Management Co. now owns 33,778 shares of the pharmacy operator's stock valued at $3,494,000 after acquiring an additional 1,578 shares during the last quarter. Wedbush Securities Inc. boosted its position in shares of CVS Health by 3.1% in the 2nd quarter. Wedbush Securities Inc. now owns 14,155 shares of the pharmacy operator's stock worth $1,464,000 after purchasing an additional 427 shares during the last quarter. Greenleaf Trust increased its holdings in CVS Health by 4.1% in the second quarter. Greenleaf Trust now owns 17,412 shares of the pharmacy operator's stock valued at $1,801,000 after purchasing an additional 679 shares during the last quarter. Capital Advisors Inc. OK boosted its holdings in CVS Health by 1.6% during the second quarter. Capital Advisors Inc. OK now owns 15,151 shares of the pharmacy operator's stock worth $1,567,000 after buying an additional 238 shares during the last quarter. Finally, New Mexico Educational Retirement Board grew its position in shares of CVS Health by 7.6% during the 2nd quarter. New Mexico Educational Retirement Board now owns 63,377 shares of the pharmacy operator's stock worth $6,556,000 after buying an additional 4,500 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Up 0.2%

NYSE:CVS opened at $93.15 on Friday. The firm has a market capitalization of $119.14 billion, a price-to-earnings ratio of 24.64, a price-to-earnings-growth ratio of 0.91 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The stock's 50 day moving average price is $101.42 and its two-hundred day moving average price is $89.46.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.9%. CVS Health's dividend payout ratio is currently 70.37%.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Pharmacy momentum supports the turnaround case. Rising prescription volumes, gains associated with Rite Aid and improving pharmacy profitability could provide support for CVS’s second-half outlook. This adds to the company’s recent earnings momentum, including revenue growth and an earnings beat in its latest reported quarter. How CVS' Pharmacy and Consumer Wellness Is Positioned for H2 2026
• Positive Sentiment: Updated flu vaccines are now available nationwide. CVS Pharmacy and MinuteClinic are offering the 2026–2027 vaccines, while expanded testing and treatment services may increase seasonal customer traffic. A company survey found that more than 60% of consumers are likely to get a flu shot, though the earnings effect is likely to be seasonal and modest. CVS Pharmacy and MinuteClinic Now Offering Updated Flu Vaccines Nationwide
• Positive Sentiment: Value-focused coverage is reinforcing rebound expectations. Zacks characterizes CVS as a potential long-term value stock, while Trefis notes that the company’s historical drawdowns have often eventually recovered. These are sentiment and valuation arguments rather than new financial guidance, but they may attract investors seeking a healthcare turnaround at a relatively reasonable valuation. Why CVS Health Is a Top Value Stock for the Long-Term
• Neutral Sentiment: ACA insurer exits create both opportunity and uncertainty. Cigna, Molina and other carriers are leaving Obamacare exchanges in 2027. The disruption could create enrollment opportunities for Aetna, CVS’s insurance business, but also highlights regulatory, pricing and membership risks across the sector. All the Insurers Exiting ACA Obamacare Exchanges for 2027
• Negative Sentiment: Political pressure on vertically integrated healthcare companies remains a risk. Mark Cuban’s support for breaking up “big medicine” adds to scrutiny of insurers, pharmacy benefit managers and large healthcare platforms. No specific policy action against CVS was announced, but potential structural or regulatory changes could weigh on sentiment. Mark Cuban Backs Plan to Break Up Big Medicine

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CVS shares. Morgan Stanley boosted their target price on CVS Health from $106.00 to $111.00 and gave the company an "overweight" rating in a research note on Thursday, June 4th. Deutsche Bank Aktiengesellschaft lifted their price objective on CVS Health from $88.00 to $92.00 and gave the company a "buy" rating in a report on Thursday, May 7th. Piper Sandler restated an "overweight" rating on shares of CVS Health in a report on Wednesday. JPMorgan Chase & Co. lifted their price target on CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. Finally, Mizuho lifted their target price on CVS Health from $110.00 to $115.00 and gave the company an "outperform" rating in a research report on Monday, June 8th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and an average price target of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source